Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 21469928)

1.

Early detection and intervention for attention-deficit/hyperactivity disorder.

Sonuga-Barke EJ, Koerting J, Smith E, McCann DC, Thompson M.

Expert Rev Neurother. 2011 Apr;11(4):557-63. doi: 10.1586/ern.11.39. Review.

PMID:
21469928
3.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
4.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

5.

Attention deficit hyperactivity disorder in preschool children.

Greenhill LL, Posner K, Vaughan BS, Kratochvil CJ.

Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):347-66, ix. doi: 10.1016/j.chc.2007.11.004. Review.

PMID:
18295150
6.

The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder.

Kratochvil CJ, Greenhill LL, March JS, Burke WJ, Vaughan BS.

CNS Drugs. 2004;18(14):957-66. Review.

PMID:
15584766
7.

Frontiers between attention deficit hyperactivity disorder and bipolar disorder.

Galanter CA, Leibenluft E.

Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):325-46, viii-ix. doi: 10.1016/j.chc.2007.11.001. Review.

PMID:
18295149
8.

Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).

[No authors listed]

NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. Review.

PMID:
10868163
9.

Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention?

Sonuga-Barke EJ, Halperin JM.

J Child Psychol Psychiatry. 2010 Apr;51(4):368-89. doi: 10.1111/j.1469-7610.2009.02195.x. Epub 2009 Dec 8. Review.

PMID:
20015192
10.
11.
12.
13.

Treatment of attention-deficit/hyperactivity disorder.

Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R.

Evid Rep Technol Assess (Summ). 1999 Nov;(11):i-viii, 1-341.

14.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
15.

Pharmacologic treatment of attention-deficit hyperactivity disorder.

Greydanus DE.

Indian J Pediatr. 2005 Nov;72(11):953-60. Review.

PMID:
16391451
16.

Economic implications of attention-deficit hyperactivity disorder for healthcare systems.

Leibson CL, Long KH.

Pharmacoeconomics. 2003;21(17):1239-62. Review.

PMID:
14986737
17.

Attention deficit hyperactivity disorder symptoms mediate early-onset smoking.

Huizink AC, van Lier PA, Crijnen AA.

Eur Addict Res. 2009;15(1):1-9. doi: 10.1159/000173003. Epub 2008 Dec 3.

PMID:
19052457
18.

A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Developments in treatment.

Levy F.

Aust N Z J Psychiatry. 2002 Aug;36(4):477-9. No abstract available.

PMID:
12169142
19.

A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Embedding categorical constructs in contemporary child mental health approaches.

McDermott BM, Gibbon P.

Aust N Z J Psychiatry. 2002 Aug;36(4):481-3. No abstract available.

PMID:
12169144
20.

Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK.

Prasad S, Arellano J, Steer C, Libretto SE.

Int J Clin Pract. 2009 Jul;63(7):1031-40. doi: 10.1111/j.1742-1241.2009.02090.x. Review.

PMID:
19570121
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk